Claritas Pharmaceuticals Inc
XTSX:CLAS
Cash Flow Statement
Cash Flow Statement
Claritas Pharmaceuticals Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
(16)
|
(4)
|
4
|
(12)
|
(3)
|
(5)
|
|
| Change in Deffered Taxes |
(9)
|
(5)
|
(5)
|
(5)
|
0
|
0
|
|
| Other Non-Cash Items |
18
|
9
|
1
|
18
|
4
|
4
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(7)
N/A
|
0
N/A
|
(0)
N/A
|
(1)
-96%
|
(0)
+33%
|
(1)
-135%
|
|
| Investing Cash Flow | |||||||
| Other Items |
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
+97%
|
0
N/A
|
0
+150%
|
(0)
N/A
|
(0)
N/A
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
6
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
7
N/A
|
0
-93%
|
0
-37%
|
1
+124%
|
1
+8%
|
0
-31%
|
|
| Change in Cash | |||||||
| Net Change in Cash |
(0)
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
+984%
|
(0)
N/A
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(7)
N/A
|
0
N/A
|
(0)
N/A
|
(1)
-96%
|
(0)
+33%
|
(1)
-135%
|
|